Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses

Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses

Show other versions (1)

© 2018 Elsevier Inc. T cells expressing chimeric antigen receptors (CARs) are promising cancer therapeutic agents, with the prospect of becoming the ultimate smart cancer therapeutics. To expand the capability of CAR T cells, here, we present a split, universal, and programmable (SUPRA) CAR system t...

Full description

Bibliographic Details
Main Authors:	Cho, Jang Hwan, Collins, James J, Wong, Wilson W
Format:	Article
Language:	English
Published:	Elsevier BV 2021
Online Access:	https://hdl.handle.net/1721.1/135450

Similar Items

Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
by: Cho, Jang Hwan, et al.
Published: (2022)

Dissecting the impact of chimeric antigen receptor expression levels on T cell behaviour and response
by: Ramos, AS
Published: (2022)

Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
by: Munisvaradass, Rusheni, et al.
Published: (2017)

Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
by: Jan, Max, et al.
Published: (2021)

A quantitative analysis of the contribution of costimulation to T cell activation by the T cell receptor and chimeric antigen receptors
by: Patel, AB
Published: (2023)

Engineering advanced logic and distributed computing in human CAR immune cells
by: Cho, Jang Hwan, et al.
Published: (2022)

Engineering advanced logic and distributed computing in human CAR immune cells
by: Cho, Jang Hwan, et al.
Published: (2021)

Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors
by: Burton, J, et al.
Published: (2023)

Chimeric antigen receptors and regulatory T cells: the potential for HLA-specific immunosuppression in transplantation
by: Wright, S, et al.
Published: (2021)

Current and future perspectives of chimeric antigen receptors against glioblastoma
by: Siller-Farfán, JA, et al.
Published: (2022)

Engineering VHH-based chimeric antigen receptor (CAR) T cell therapy for solid tumor treatment
by: Xie, Yushu Joy.
Published: (2019)

Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma
by: Ernst, M, et al.
Published: (2021)

A ray of hope in a dire situation: Radiotherapy for progression after chimeric antigen receptor T‐cell therapy
by: Shakir, RF, et al.
Published: (2020)

Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive
by: Mohseni, YR, et al.
Published: (2021)

Engineering of a third-generation chimeric antigen receptor with specificity for HLA-A2 for use in regulatory T cell therapy
by: Wright, S
Published: (2022)

Structure-based design of chimeric antigens for multivalent protein vaccines
by: Hollingshead, S, et al.
Published: (2018)

Addition of the C‐terminus of CD6 to a chimeric antigen receptor enhances cytotoxicity and does not compromise expression
by: Breuning, J, et al.
Published: (2018)

Evaluation of two short tandem repeat multiplex systems for post-haematopoietic stem cell transplantation chimerism analysis.
by: Ariffin, H., et al.
Published: (2007)

Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors.
by: Yun, C, et al.
Published: (2000)

Rhabdomyosarcoma lysis by T cells expressing a human autoantibody-based chimeric receptor targeting the fetal acetylcholine receptor.
by: Gattenlöhner, S, et al.
Published: (2006)

Human CD3+ T-cells with the anti-ERBB2 chimeric antigen receptor exhibit efficient targeting and induce apoptosis in ERBB2 overexpressing breast cancer cells
by: Munisvaradass, Rusheni, et al.
Published: (2017)

Chimeric antigens displaying GPR65 extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor
by: Barrett, J, et al.
Published: (2024)

The immunogenicity of chimeric antibodies.
by: Brüggemann, M, et al.
Published: (1989)

Tailoring Chimeric Ligands for Studying and Biasing ErbB Receptor Family Interactions
by: Krueger, Andrew T., et al.
Published: (2015)

Developmental failure of chimeric embryos expressing high levels of H-2Dd transplantation antigens.
by: Jaffe, L, et al.
Published: (1992)

Multiplex Human Malaria Array: Quantifying Antigens for Malaria Rapid Diagnostics
by: Jang, IK, et al.
Published: (2020)

Utilizing in vivo genome-wide CRISPR/Cas9 screens in immunocompetent mouse models to identify novel tumor liabilities and explore mechanisms of resistance to Chimeric Antigen Receptor T-cell therapy
by: Koch, Catherine E.
Published: (2024)

T-cell antigen receptor expression in the thymus.
by: Acuto, O, et al.
Published: (1987)

Redirecting the cellular information flow with programmable dCas9-based chimeric receptors
by: Baeumler, TA
Published: (2018)

Engineering synthetic signalling pathways with programmable dCas9-based chimeric receptors
by: Baeumler, T, et al.
Published: (2017)

Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning
by: Graca, L, et al.
Published: (2006)

Assessment of Plasmodium antigens and CRP in dried blood spots with multiplex malaria array
by: Jang, IK, et al.
Published: (2021)

Relative affinity and avidity of the antigen-binding receptors of T and B rosette-forming cells.
by: Wilson, J, et al.
Published: (1973)

Delivery of chimeric hepatitis B core particles into liver cells.
by: Tan, Wen Siang, et al.
Published: (2012)

Molecular analysis of the human T-cell-antigen receptor.
by: Acuto, O, et al.
Published: (1985)

T cell receptor sequence clustering and antigen specificity
by: M Vujovic, et al.
Published: (2020)

The roles of processing, presentation and T cell receptor recognition in the T lymphocyte response to a protein antigen
by: Szabo, Alexander Andrew
Published: (2006)

Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites
by: Kolli, SK, et al.
Published: (2021)

Multiplexed rapid antigen tests developed using multicolored nanoparticles and cross-reactive antibody pairs: Implications for pandemic preparedness
by: de Puig, Helena, et al.
Published: (2023)

Engineering chimeric human and mouse Major Histocompatibility Complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies
by: Li, D, et al.
Published: (2017)